{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T05:43:28Z","timestamp":1750052608105},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1097\/jcp.0000000000000331","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T09:36:39Z","timestamp":1429176999000},"page":"350-351","source":"Crossref","is-referenced-by-count":9,"title":["Exacerbation of Tics After Combining Aripiprazole With Pimozide"],"prefix":"10.1097","volume":"35","author":[{"given":"Bet\u00fcl","family":"Mazlum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sennur","family":"Zaimo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didem Behice","family":"\u00d6ztop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"4","key":"R1-31-20210128","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/cap.2009.0118","article-title":"Neurobiological substrates of Tourettes disorder.","volume":"20","author":"Leckman","year":"2010","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R2-31-20210128","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neuropharm.2012.05.043","article-title":"Pharmacological treatment of tic disorders and Tourette Syndrome.","volume":"68","author":"Roessner","year":"2013","journal-title":"Neuropharmacology"},{"issue":"7","key":"R3-31-20210128","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00787-012-0270-0","article-title":"Efficacy and safety of aripiprazole in child and adolescent patients.","volume":"21","author":"Kirino","year":"2012","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"8","key":"R4-31-20210128","doi-asserted-by":"crossref","first-page":"e772","DOI":"10.4088\/JCP.12m08189","article-title":"A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourettes disorder.","volume":"74","author":"Yoo","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"R5-31-20210128","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity.","volume":"28","author":"Leckman","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"8","key":"R6-31-20210128","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with unique and robust pharmacology.","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"R7-31-20210128","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0149-2918(04)90066-5","article-title":"Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability.","volume":"26","author":"DeLeon","year":"2004","journal-title":"Clin Ther"},{"issue":"2","key":"R8-31-20210128","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2710.2008.00996.x","article-title":"Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.","volume":"34","author":"Adan-Manes","year":"2009","journal-title":"J Clin Pharm Ther"},{"issue":"2","key":"R9-31-20210128","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00213-013-3154-1","article-title":"A systematic review of reported cases involving psychotic symptoms worsened by aripiprazole in schizophrenia or schizoaffective disorder.","volume":"228","author":"Takeuchi","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"R11-31-20210128","doi-asserted-by":"crossref","first-page":"9856","DOI":"10.1523\/JNEUROSCI.21-24-09856.2001","article-title":"Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism.","volume":"21","author":"Martin-Ruiz","year":"2001","journal-title":"J Neurosci"},{"issue":"4","key":"R12-31-20210128","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1399-5618.2012.01022.x","article-title":"The functional neuroanatomy of bipolar disorder: a consensus model.","volume":"14","author":"Strakowski","year":"2012","journal-title":"Bipolar Disord"},{"issue":"8","key":"R13-31-20210128","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.biopsych.2008.05.014","article-title":"Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania.","volume":"64","author":"Ongur","year":"2008","journal-title":"Biol Psychiatry"},{"issue":"2","key":"R14-31-20210128","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/JCP.0b013e31824929d6","article-title":"The psychopharmacology of aggressive behavior: a translational approach: part 2: clinical studies using atypical antipsychotics, anticonvulsants, and lithium.","volume":"32","author":"Comai","year":"2012","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"R15-31-20210128","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2010.01.010","article-title":"Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway.","volume":"471","author":"Ishii","year":"2010","journal-title":"Neurosci Lett"},{"issue":"10","key":"R16-31-20210128","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.4088\/JCP.09m05164yel","article-title":"Acute treatment of pediatric bipolar 1 disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study.","volume":"70","author":"Findling","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"R17-31-20210128","first-page":"37","article-title":"First manic episode in a 55-year-old man after initiation of aripiprazole.","volume":"7","author":"Donohue","year":"2010","journal-title":"Psychiatry (Edgmont)"},{"issue":"3","key":"R18-31-20210128","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jpsychores.2006.07.019","article-title":"Mood disorders and Gilles de la Tourettes syndrome: an update on prevalence, etiology, comorbidity, clinical associations, and implications.","volume":"61","author":"Robertson","year":"2006","journal-title":"J Psychosom Res"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0000000000000331","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:48:34Z","timestamp":1620956914000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201506000-00031"}},"subtitle":["A Case With Tourette Syndrome"],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0000000000000331","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}